FDA Pfizer Vaccine Approval

News

New COVID-19 Vaccine on Track for FDA Approval

As FDA delays Novavax' COVID vaccine approval, patients fight back

By Julie Steenhuysen CHICAGO (Reuters) -Thousands of Americans campaigning for the Novavax COVID-19 booster got some good news this week: the FDA signaled it might still win approval after Health Secretary Robert F.

The Associated Press on MSN · 22h

Novavax: New COVID-19 Vaccine on Track for FDA Approval

The company says its vaccine is on track for full approval, following delay. Novavax shares soared following the announcement.

Benzinga · 21h

Novavax's COVID-19 Vaccine Nears FDA Full Approval, Stock Jumps

Novavax's COVID-19 vaccine showed fewer side effects than Pfizer's in a Utah study as FDA seeks more data before full approval decision.

STAT13d

Health secretary RFK Jr. declares certain vaccines have ‘never worked,’ flummoxing scientists

Health secretary Robert F. Kennedy Jr. has expressed another unorthodox view on vaccines, declaring that single antigen ...

Investopedia4d

Top Pfizer Shareholders

Pfizer is a pharmaceutical and biotechnology company that developed a COVID-19 vaccine that was approved by the FDA in August 2021. The three top individual/insider shareholders in Pfizer ...

Some results have been hidden because they may be inaccessible to you

Show inaccessible results

News

New COVID-19 Vaccine on Track for FDA Approval

Trending now